Comparison of variant allele frequency and number of mutant molecules as units of measurement for circulating tumor DNA von Bos, Manouk K., Nasserinejad, Kazem, Jansen, Maurice P. H. M., Angus, Lindsay, Atmodimedjo, Peggy N., Jonge, Evert, Dinjens, Winand N. M., Schaik, Ron H. N., Del Re, Marzia, Dubbink, Hendrikus J., Sleijfer, Stefan, Martens, John W. M.

Volltext

Quantitative modeling of tumor dynamics and development of drug resistance in non‐small cell lung cancer patients treated with erlotinib von Yin, Anyue, Veerman, G. D. Marijn, Hasselt, Johan G. C., Steendam, Christi M. J., Dubbink, Hendrikus Jan, Guchelaar, Henk‐Jan, Friberg, Lena E., Dingemans, Anne‐Marie C., Mathijssen, Ron H. J., Moes, Dirk Jan A. R.

Volltext

Plasma Predictive Features in Treating EGFR-Mutated Non-Small Cell Lung Cancer von Steendam, Christi M. J., Veerman, G. D. Marijn, Pruis, Melinda A., Atmodimedjo, Peggy, Paats, Marthe S., van der Leest, Cor, von der Thusen, Jan H., Yick, David C. Y., Oomen-de Hoop, Esther, Koolen, Stijn L. W., Dinjens, Winand N. M., van Schaik, Ron H. N., Mathijssen, Ron H. J., Aerts, Joachim G. J. V., Dubbink, Hendrikus Jan, Dingemans, Anne-Marie C.

Volltext

Osimertinib Plasma Trough Concentration in Relation to Brain Metastases Development in Patients With Advanced EGFR-Mutated NSCLC von Gulikers, Judith L., Veerman, G.D. Marijn, Jebbink, Merel, Kruithof, Paul D., Steendam, Christi M.J., Boosman, René J., Mathijssen, Ron H.J., Tjan-Heijnen, Vivianne C.G., Driessen, Johanna H.M., Dursun, Safiye, Smit, Egbert F., Dingemans, Anne-Marie C., van Geel, Robin M.J.M., Croes, Sander, Hendriks, Lizza E.L.

Volltext

Chemotherapy for patients with EGFR-mutated NSCLC after progression on EGFR-TKI’s: Exploration of efficacy of unselected treatment in a multicenter cohort study von Steendam, Christi M.J., Ernst, Sophie M., Badrising, Sushil K., Paats, Marthe S., Aerts, Joachim G.J.V., de Langen, Adrianus J., Dingemans, Anne-Marie C.

Volltext

Exploring the impact of patient‐specific clinical features on osimertinib effectiveness in a real‐world cohort of patients with EGFR mutated non‐small cell lung cancer von Veelen, Ard, Veerman, G. D. Marijn, Verschueren, Marjon V., Gulikers, Judith L., Steendam, Christi M. J., Brouns, Anita J. W. M., Dursun, Safiye, Paats, Marthe S., Tjan‐Heijnen, Vivianne C. G., Leest, Cor, Dingemans, Anne‐Marie C., Mathijssen, Ron H. J., Garde, Ewoudt M. W., Souverein, Patrick, Driessen, Johanna H. M., Hendriks, Lizza E. L., Geel, Robin M. J. M., Croes, Sander

Volltext

Improving the tolerability of osimertinib by identifying its toxic limit von Agema, Bram C., Veerman, G. D. Marijn, Steendam, Christi M. J., Lanser, Daan A. C., Preijers, Tim, van der Leest, Cor, Koch, Birgit C. P., Dingemans, Anne-Marie C., Mathijssen, Ron H. J., Koolen, Stijn L. W.

Volltext

Exploring the impact of patient-specific clinical features on osimertinib effectiveness in a real-world cohort of patients with EGFR mutated non-small cell lung cancer von van Veelen, Ard, Veerman, G. D.Marijn, Verschueren, Marjon V, Gulikers, Judith L, Steendam, Christi M.J, Brouns, Anita J.W.M, Dursun, Safiye, Paats, Marthe S, Tjan-Heijnen, Vivianne C.G, van der Leest, Cor, Dingemans, Anne Marie C, Mathijssen, Ron H.J, van de Garde, Ewoudt M.W, Souverein, Patrick, Driessen, Johanna H.M, Hendriks, Lizza E.L, van Geel, Robin M.J.M, Croes, Sander

Volltext

Influence of Cow’s Milk and Esomeprazole on the Absorption of Erlotinib: A Randomized, Crossover Pharmacokinetic Study in Lung Cancer Patients von Veerman, G. D. Marijn, Hussaarts, Koen G. A. M., Peric, Robert, Oomen-de Hoop, Esther, Landa, Kersten D., van der Leest, Cor H., Broerse, Suzanna D., Rutten, Hugo B., Belderbos, Huub N. A., Steendam, Christi M. J., Paats, Marthe S., Koolen, Stijn L. W., Dingemans, Anne-Marie C., van Gelder, Teun, van Leeuwen, Roelof W. F., Aerts, Joachim G. J. V., Mathijssen, Ron H. J.

Volltext

Randomized phase III study of docetaxel versus docetaxel plus intercalated erlotinib in patients with relapsed non-squamous non-small cell lung carcinoma von Steendam, Christi M.J., Peric, Robert, van Walree, Nico C., Youssef, Magdolen, Schramel, Franz M.N.H., Brocken, Pepijn, van Putten, John W.G., van der Noort, Vincent, Veerman, G.D. Marijn, Koolen, Stijn L.W., Groen, Harry J.M., Dingemans, Anne-Marie C., Mathijssen, Ron H.J., Smit, Egbert F., Aerts, Joachim G.J.V.

Volltext

Patients with NSCLC may display a low ratio of p.T790M vs. activating EGFR mutations in plasma at disease progression: implications for personalised treatment von Del Re, Marzia, Bordi, Paola, Petrini, Iacopo, Rofi, Eleonora, Mazzoni, Francesca, Belluomini, Lorenzo, Vasile, Enrico, Restante, Giuliana, Di Costanzo, Francesco, Falcone, Alfredo, Frassoldati, Antonio, van Schaik, Ron H N, Steendam, Christi M J, Chella, Antonio, Tiseo, Marcello, Morganti, Riccardo, Danesi, Romano

Volltext

Immunotherapeutic strategies in non-small-cell lung cancer: the present and the future von J Steendam, Christi M, Dammeijer, Floris, Aerts, Joachim G J V, Cornelissen, Robin

Volltext

Influence of germline variations in drug transporters ABCB1 and ABCG2 on intracerebral osimertinib efficacy in patients with non-small cell lung cancer von Veerman, G.D. Marijn, Boosman, Rene J., Jebbink, Merel, Oomen-de Hoop, Esther, van der Wekken, Anthonie J., Bahce, Idris, Hendriks, Lizza E.L., Croes, Sander, Steendam, Christi M.J., de Jonge, Evert, Koolen, Stijn L.W., Steeghs, Neeltje, van Schaik, Ron H.N., Smit, Egbert F., Dingemans, Anne-Marie C., Huitema, Alwin D.R., Mathijssen, Ron H.J.

Volltext

Influence of germline variations in drug transporters ABCB1 and ABCG2 on intracerebral osimertinib efficacy in patients with non-small cell lung cancerResearch in context von G.D. Marijn Veerman, Rene J. Boosman, Merel Jebbink, Esther Oomen-de Hoop, Anthonie J. van der Wekken, Idris Bahce, Lizza E.L. Hendriks, Sander Croes, Christi M.J. Steendam, Evert de Jonge, Stijn L.W. Koolen, Neeltje Steeghs, Ron H.N. van Schaik, Egbert F. Smit, Anne-Marie C. Dingemans, Alwin D.R. Huitema, Ron H.J. Mathijssen

Volltext